A Meta-analysis of Prophylaxis of Surgical Site Infections with Topical Application of Povidone Iodine Before Primary Closure.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 24 9 2018
medline: 14 6 2019
entrez: 24 9 2018
Statut: ppublish

Résumé

Povidone iodine (PVI) is a widely used antiseptic solution among surgeons. A meta-analysis based on randomized controlled trials (RCTs) was conducted to establish whether application of PVI before wound closure could reduce surgical site infection (SSI) rates. Systematic review of MEDLINE/PubMed, Scopus, CINAHL, and Web of Science databases from inception to September 2017, with no language restrictions. Only RCTs were retrieved. The primary outcome was the SSI rate. Meta-analysis was complemented with trial sequential analysis (TSA). A total of 7601 patients collected from 16 RCTs were analyzed. A reduction in overall SSI rate was found (RR 0.64, 95% CI 0.48-0.85, P = 0.002, I There is no conclusive evidence for a strong recommendation of topical PVI before wound closure to prevent SSI.

Sections du résumé

BACKGROUND BACKGROUND
Povidone iodine (PVI) is a widely used antiseptic solution among surgeons. A meta-analysis based on randomized controlled trials (RCTs) was conducted to establish whether application of PVI before wound closure could reduce surgical site infection (SSI) rates.
METHODS METHODS
Systematic review of MEDLINE/PubMed, Scopus, CINAHL, and Web of Science databases from inception to September 2017, with no language restrictions. Only RCTs were retrieved. The primary outcome was the SSI rate. Meta-analysis was complemented with trial sequential analysis (TSA).
RESULTS RESULTS
A total of 7601 patients collected from 16 RCTs were analyzed. A reduction in overall SSI rate was found (RR 0.64, 95% CI 0.48-0.85, P = 0.002, I
CONCLUSIONS CONCLUSIONS
There is no conclusive evidence for a strong recommendation of topical PVI before wound closure to prevent SSI.

Identifiants

pubmed: 30244376
doi: 10.1007/s00268-018-4798-0
pii: 10.1007/s00268-018-4798-0
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Povidone-Iodine 85H0HZU99M
Iodine 9679TC07X4

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-384

Références

Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80
pubmed: 10219875
Br J Surg. 1975 Apr;62(4):292-4
pubmed: 1093604
Appl Nurs Res. 2002 Aug;15(3):197-8
pubmed: 12173172
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Int J Dermatol. 1992 May;31(5):359-60
pubmed: 1587669
J Bone Joint Surg Am. 2005 Jul;87(7):1415-22
pubmed: 15995106
Spine (Phila Pa 1976). 2005 Aug 1;30(15):1689-93
pubmed: 16094267
Eur Spine J. 2006 Jun;15(6):1005-14
pubmed: 16133077
Dermatology. 2006;212 Suppl 1:53-7
pubmed: 16490976
Am J Med. 1991 Sep 16;91(3B):152S-157S
pubmed: 1656747
Ann Thorac Surg. 1992 Feb;53(2):301-5
pubmed: 1731672
Acta Chir Orthop Traumatol Cech. 2008 Apr;75(2):106-9
pubmed: 18454914
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Arch Intern Med. 2010 May 10;170(9):749-50
pubmed: 20458080
J Int Med Res. 2010 Jul-Aug;38(4):1287-93
pubmed: 20926001
J Hosp Infect. 2011 Apr;77(4):363-4
pubmed: 21257229
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
PLoS One. 2011;6(10):e25491
pubmed: 22028777
ANZ J Surg. 2013 Nov;83(11):844-6
pubmed: 23360528
Mayo Clin Proc. 2013 Aug;88(8):790-8
pubmed: 23871230
BMJ. 2015 Jun 03;350:h2463
pubmed: 26041754
Aust N Z J Obstet Gynaecol. 2016 Jun;56(3):301-6
pubmed: 26847398
Injury. 2016 Sep;47(9):1913-8
pubmed: 27269416
J Hosp Infect. 2016 Aug;93(4):319-22
pubmed: 27388057
Lancet Infect Dis. 2016 Dec;16(12):e276-e287
pubmed: 27816413
Lancet Infect Dis. 2016 Dec;16(12):e288-e303
pubmed: 27816414
Cochrane Database Syst Rev. 2016 Nov 07;11:CD011426
pubmed: 27819748
Surg Infect (Larchmt). 2017 May/Jun;18(4):508-519
pubmed: 28448203
J Hosp Infect. 1985 Mar;6 Suppl A:103-14
pubmed: 2860153
Ann R Coll Surg Engl. 1988 Sep;70(5):313-6
pubmed: 3056208
Br J Surg. 1978 Feb;65(2):89-91
pubmed: 342043
Br J Surg. 1986 Dec;73(12):958-60
pubmed: 3790957
Surg Gynecol Obstet. 1979 Feb;148(2):227-31
pubmed: 419426
Surg Forum. 1977;28:48-51
pubmed: 617510
Ann R Coll Surg Engl. 1983 Nov;65(6):397-9
pubmed: 6357036
Surg Gynecol Obstet. 1983 Nov;157(5):426-30
pubmed: 6635913
Br J Surg. 1981 Mar;68(3):185-9
pubmed: 7008894
Injury. 1980 Sep;12(2):104-6
pubmed: 7009430
Br J Surg. 1981 May;68(5):310-3
pubmed: 7013895
Ir Med J. 1982 Mar;75(3):96
pubmed: 7042641
Surg Gynecol Obstet. 1982 Aug;155(2):221-4
pubmed: 7048591
Am J Surg. 1981 Sep;142(3):393-7
pubmed: 7283035
Surg Clin North Am. 1980 Feb;60(1):27-40
pubmed: 7361226
Lancet. 1978 Apr 8;1(8067):769
pubmed: 76769
Br J Surg. 1975 Oct;62(10):792-9
pubmed: 811302

Auteurs

Manuel López-Cano (M)

Department of General Surgery, Abdominal Wall Surgery Unit and General and Digestive Surgery Research Group, Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. mlpezcano@gmail.com.

Miquel Kraft (M)

Department of General Surgery, Abdominal Wall Surgery Unit and General and Digestive Surgery Research Group, Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Anna Curell (A)

Department of General Surgery, Abdominal Wall Surgery Unit and General and Digestive Surgery Research Group, Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Mireia Puig-Asensio (M)

Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Barcelona, Spain.

José Balibrea (J)

Department of General Surgery, Abdominal Wall Surgery Unit and General and Digestive Surgery Research Group, Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Manuel Armengol-Carrasco (M)

Department of General Surgery, Abdominal Wall Surgery Unit and General and Digestive Surgery Research Group, Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Josep M García-Alamino (JM)

Evidence-Based Healthcare, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH